Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

Scheinberg, 2011, Horse versus rabbit antithymocyte globulin in acquired aplastic anemia, N Engl J Med, 365, 430, 10.1056/NEJMoa1103975 Feng, 2011, Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes, Haematologica, 96, 602, 10.3324/haematol.2010.030536 Schrezenmeier, 1998, Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission, Br J Haematol, 100, 571, 10.1046/j.1365-2141.1998.00590.x Singh, 2015, Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity, Asian J Transfus Sci, 9, 70, 10.4103/0973-6247.150956 Emmons, 1996, Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction, Blood, 87, 4068, 10.1182/blood.V87.10.4068.bloodjournal87104068 Gurion, 2009, Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy: systematic review and meta-analysis, Haematologica, 94, 712, 10.3324/haematol.2008.002170 Marsh, 2000, Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia, Semin Hematol, 37, 81, 10.1016/S0037-1963(00)90032-5 Desmond, 2014, Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug, Blood, 123, 1818, 10.1182/blood-2013-10-534743 Townsley, 2017, Eltrombopag added to standard immunosuppression for aplastic anemia, N Engl J Med, 376, 1540, 10.1056/NEJMoa1613878 Olnes, 2012, Eltrombopag and improved hematopoiesis in refractory aplastic anemia, N Engl J Med, 367, 11, 10.1056/NEJMoa1200931 Camitta, 1988, Criteria for severe aplastic anaemia, Lancet, 1, 303, 10.1016/S0140-6736(88)90388-1 Ninan, 2007, Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation, Biol Blood Marrow Transplant, 13, 895, 10.1016/j.bbmt.2007.04.001 Sungaran, 1997, Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization, Blood, 89, 101, 10.1182/blood.V89.1.101 Fielder, 1996, Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets, Blood, 87, 2154, 10.1182/blood.V87.6.2154.bloodjournal8762154 Qian, 2007, Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells, Cell Stem Cell, 1, 671, 10.1016/j.stem.2007.10.008 Erickson-Miller, 2009, Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist, Stem Cells, 27, 424, 10.1634/stemcells.2008-0366 Cheng, 2016, Interferon-gamma perturbs key signaling pathways induced by thrombopoietin, but not eltrombopag, in human hematopoietic stem/progenitor cells, Blood, 128, 3870, 10.1182/blood.V128.22.3870.3870